BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 17322882)

  • 1. Complete inactivation of DNMT1 leads to mitotic catastrophe in human cancer cells.
    Chen T; Hevi S; Gay F; Tsujimoto N; He T; Zhang B; Ueda Y; Li E
    Nat Genet; 2007 Mar; 39(3):391-6. PubMed ID: 17322882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CpG island hypermethylation is maintained in human colorectal cancer cells after RNAi-mediated depletion of DNMT1.
    Ting AH; Jair KW; Suzuki H; Yen RW; Baylin SB; Schuebel KE
    Nat Genet; 2004 Jun; 36(6):582-4. PubMed ID: 15156141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Major and essential role for the DNA methylation mark in mouse embryogenesis and stable association of DNMT1 with newly replicated regions.
    Takebayashi S; Tamura T; Matsuoka C; Okano M
    Mol Cell Biol; 2007 Dec; 27(23):8243-58. PubMed ID: 17893328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CXXC domain of human DNMT1 is essential for enzymatic activity.
    Pradhan M; Estève PO; Chin HG; Samaranayke M; Kim GD; Pradhan S
    Biochemistry; 2008 Sep; 47(38):10000-9. PubMed ID: 18754681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal regulation of DNA methyltransferase expression during colorectal carcinogenesis.
    De Marzo AM; Marchi VL; Yang ES; Veeraswamy R; Lin X; Nelson WG
    Cancer Res; 1999 Aug; 59(16):3855-60. PubMed ID: 10463569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The activity of the murine DNA methyltransferase Dnmt1 is controlled by interaction of the catalytic domain with the N-terminal part of the enzyme leading to an allosteric activation of the enzyme after binding to methylated DNA.
    Fatemi M; Hermann A; Pradhan S; Jeltsch A
    J Mol Biol; 2001 Jun; 309(5):1189-99. PubMed ID: 11399088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNMT1 but not its interaction with the replication machinery is required for maintenance of DNA methylation in human cells.
    Spada F; Haemmer A; Kuch D; Rothbauer U; Schermelleh L; Kremmer E; Carell T; Längst G; Leonhardt H
    J Cell Biol; 2007 Feb; 176(5):565-71. PubMed ID: 17312023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Doxorubicin inhibits DNMT1, resulting in conditional apoptosis.
    Yokochi T; Robertson KD
    Mol Pharmacol; 2004 Dec; 66(6):1415-20. PubMed ID: 15340041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential requirement for DNA methyltransferase 1 in maintaining human cancer cell gene promoter hypermethylation.
    Ting AH; Jair KW; Schuebel KE; Baylin SB
    Cancer Res; 2006 Jan; 66(2):729-35. PubMed ID: 16424002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mithramycin A inhibits DNA methyltransferase and metastasis potential of lung cancer cells.
    Lin RK; Hsu CH; Wang YC
    Anticancer Drugs; 2007 Nov; 18(10):1157-64. PubMed ID: 17893516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNMT1 silencing affects locus specific DNA methylation and increases prostate cancer derived PC3 cell invasiveness.
    Yaqinuddin A; Qureshi SA; Qazi R; Farooq S; Abbas F
    J Urol; 2009 Aug; 182(2):756-61. PubMed ID: 19539327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-wide analysis in a murine Dnmt1 knockdown model identifies epigenetically silenced genes in primary human pituitary tumors.
    Dudley KJ; Revill K; Whitby P; Clayton RN; Farrell WE
    Mol Cancer Res; 2008 Oct; 6(10):1567-74. PubMed ID: 18922972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The SRA protein Np95 mediates epigenetic inheritance by recruiting Dnmt1 to methylated DNA.
    Sharif J; Muto M; Takebayashi S; Suetake I; Iwamatsu A; Endo TA; Shinga J; Mizutani-Koseki Y; Toyoda T; Okamura K; Tajima S; Mitsuya K; Okano M; Koseki H
    Nature; 2007 Dec; 450(7171):908-12. PubMed ID: 17994007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of DNMT1 (DNA methyltransferase 1) hypomorphs in somatic knockouts suggests an essential role for DNMT1 in cell survival.
    Egger G; Jeong S; Escobar SG; Cortez CC; Li TW; Saito Y; Yoo CB; Jones PA; Liang G
    Proc Natl Acad Sci U S A; 2006 Sep; 103(38):14080-5. PubMed ID: 16963560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous cytosine damage products alter the site selectivity of human DNA maintenance methyltransferase DNMT1.
    Valinluck V; Sowers LC
    Cancer Res; 2007 Feb; 67(3):946-50. PubMed ID: 17283125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of DNA methyltransferase 1 expression in bovine fibroblast cells used for nuclear transfer.
    Giraldo AM; Lynn JW; Purpera MN; Vaught TD; Ayares DL; Godke RA; Bondioli KR
    Reprod Fertil Dev; 2009; 21(6):785-95. PubMed ID: 19567221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maintenance of genomic methylation patterns during preimplantation development requires the somatic form of DNA methyltransferase 1.
    Kurihara Y; Kawamura Y; Uchijima Y; Amamo T; Kobayashi H; Asano T; Kurihara H
    Dev Biol; 2008 Jan; 313(1):335-46. PubMed ID: 18048024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic disruption of cytosine DNA methyltransferase enzymes induces chromosomal instability in human cancer cells.
    Karpf AR; Matsui S
    Cancer Res; 2005 Oct; 65(19):8635-9. PubMed ID: 16204030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conditional inactivation of the mouse Hus1 cell cycle checkpoint gene.
    Levitt PS; Liu H; Manning C; Weiss RS
    Genomics; 2005 Aug; 86(2):212-24. PubMed ID: 15919177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA methyltransferase I is a mediator of doxorubicin-induced genotoxicity in human cancer cells.
    Tan HH; Porter AG
    Biochem Biophys Res Commun; 2009 May; 382(2):462-7. PubMed ID: 19292979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.